Contribution of genetic factors to the pathogenesis of Paget's disease of bone and related disorders

Journal of Bone and Mineral Research

Volumn 22, Issue SUPPL. 2, 2007, Pages

  Lucas, Gavin J A ^a   Daroszewska, Anna ^a   Ralston, Stuart H ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Expansile skeletal hyperphosphatasia; Familial expansile osteolysis; Idiopathic hyperphosphatasia; Juvenile Paget's disease; Osteoprotegerin; Paget's disease of bone; RANK; SQSTM1

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEASOME; UBIQUITIN;

ARTICLE; BONE DISEASE; FRONTOTEMPORAL DEMENTIA; GENE; GENE CLUSTER; GENE DUPLICATION; GENE MUTATION; GENETIC POLYMORPHISM; HEREDITY; HUMAN; MYOPATHY; OSTEOLYSIS; PAGET BONE DISEASE; PATHOGENESIS; SKELETAL HYPERPHOSPHATASIA; SQSTM1 GENE; TNFRSF11A GENE; TNFRSF11B GENE; GENETIC PREDISPOSITION; GENETICS; MUTATION; PATHOPHYSIOLOGY; REVIEW;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; OSTEITIS DEFORMANS;

EID: 34247874843     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.06S206     Document Type: Article

References (67)

1. Kanis JA 1992 Pathophysiology and Treatment of Paget's Disease of Bone. Martin Dunitz, London, UK.
2. Sofaer JA, Holloway SM, Emery AE 1983 A family study of Paget's disease of bone. J Epidemiol Community Health 37:226-231.
3. Siris ES, Ottman R, Flaster E, Kelsey JL 1991 Familial aggregation of Paget's disease of bone. J Bone Miner Res 6:495-500.
4. Hocking L, Slee F, Cundy T, Nicholson G, Van Hul W, Ralston SH 2000 Familial Paget's disease of Bone: Patterns of inheritance and frequency of linkage to chromosome 18q. Bone 26:577-580.
5. Osterberg PH, Wallace RG, Adams DA, Crone RS, Dickson GR, Kanis JA, Mollan RA, Nevin NC, Sloan J, Toner PG 1988 Familial expansile osteolysis. A new dysplasia. J Bone Joint Surg Br 70:255-260.
6. Whyte MP, Mills BG, Reinus WR, Podgornik MN, Roodman GD, Gannon FH, Eddy MC, McAlister WH 2000 Expansile skeletal hyperphosphatasia: A new familial metabolic bone disease. J Bone Miner Res 15:2330-2344.
7. Nakatsuka K, Nishizawa Y, Ralston SH 2003 Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. J Bone Miner Res 18:1381-1385.
8. Whyte MP, Obrecht SE, Finnegan PM, Jones JL, Podgornik MN, McAlister WH, Mumm S 2002 Osteoprotegerin deficiency and juvenile Paget's disease. N Engl J Med 347:175-184.
9. Kovach MJ, Waggoner B, Leal SM, Gelber D, Khardori R, Levenstien MA, Shanks CA, Gregg G, Al Lozi MT, Miller T, Rakowicz W, Lopate G, Florence J, Glosser G, Simmons Z, Morris JC, Whyte MP, Pestronk A, Kimonis VE 2001 Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: Hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol Genet Metab 74:458-475.
10. Meunier PJ, Coindre JM, Edouard CM, Arlot ME 1980 Bone histomorphometry in Paget's disease. Quantitative and dynamic analysis of pagetic and nonpagetic bone tissue. Arthritis Rheum 23:1095-1103.
11. van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Cooper C 2002 Incidence and natural history of Paget's disease of bone in England and Wales. J Bone Miner Res 17:465-471.
12. Barker DJ 1984 The epidemiology of Paget's disease of bone. Br Med Bull 40:396-400.
13. Cooper C, Schafheutle K, Dennison E, Kellingray S, Guyer P, Barker D 1999 The epidemiology of Paget's disease in Britain: Is the prevalence decreasing? J Bone Miner Res 14:192-197.
14. Cundy HR, Gamble G, Wattie D, Rutland M, Cundy T 2004 Paget's disease of bone in New Zealand: Continued decline in disease severity. Calcif Tissue Int 75:358-364.
15. Gennari L, Di SM, Merlotti D, Giordano N, Martini G, Tamone C, Zatteri R, De LR, Baldi C, Vattimo A, Capoccia S, Burroni L, Geraci S, De PV, Calabro A, Avanzati A, Isaia G, Nuti R 2005 Prevalence of Paget's disease of bone in Italy. J Bone Miner Res 20:1845-1850.
16. Tiegs RD, Lohse CM, Wollan PC, Melton LJ 2000 Long-term trends in the incidence of Paget's disease of bone. Bone 27:423-427.
17. Rebel A, Malkani K, Basle M, Bregeon C, Patezour A, Filmon R 1974 Ultrastructural characteristics of osteoclasts in Paget's disease. Rev Rhum Mal Osteoartic 41:767-771.
18. Mills BG, Singer FR 1976 Nuclear inclusions in Paget's disease of bone. Science 194:201-202.
19. Mee AP, May C, Bennett D, Sharpe PT 1995 Generation of multinucleated osteoclast-like cells from canine bone marrow: Effects of canine distemper virus. Bone 17:47-55.
20. Reddy SV, Kurihara N, Menaa C, Landucci G, Forthal D, Koop BA, Windle JJ, Roodman GD 2001 Osteoclasts formed by measles virus-infected osteoclast precursors from hCD46 transgenic mice express characteristics of pagetic osteoclasts. Endocrinology 142:2898-2905.
21. Kurihara N, Reddy SV, Menaa C, Anderson D, Roodman GD 2000 Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype. J Clin Invest 105:607-614.
22. Friedrichs WE, Reddy SV, Singer FR, Roodman GD 2002 The pro and con of measles virus in Paget's disease: Pro. J Bone Miner Res 17:2293.
23. Rima BK, Gassen U, Helfrich MH, Ralston SH 2002 The pro and con of measles virus in Paget's disease: Con. J Bone Miner Res 17:2290-2292.
24. Montagu MFA 1949 Paget's disease (osteitis deformans) and hereditary. Am J Hum Genet 1:94-95.
25. Morales-Piga AA, Rey-Rey JS, Corres-Gonzalez J, Garcia-Sagredo JM, Lopez-Abente G 1995 Frequency and characteristics of familial aggregation of Paget's disease of bone. J Bone Miner Res 10:663-670.
26. Laurin N, Brown JP, Lemainque A, Duchesne A, Huot D, Lacourciere Y, Drapeau G, Verreault J, Raymond V, Morissette J 2001 Paget disease of bone: Mapping of two loci at 5q35-qter and 5q31. Am J Hum Genet 69:528-543.
27. Hocking LJ, Herbert CA, Nicholls RK, Williams F, Bennett ST, Cundy T, Nicholson GC, Wuyts W, Van Hul W, Ralston SH 2001 Genomewide search in familial paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35. Am J Hum Genet 69:1055-1061.
28. Laurin N, Brown JP, Morissette J, Raymond V 2002 Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet 70:1582-1588.
29. Hocking LJ, Lucas GJA, Daroszewska A, Mangion J, Olavesen M, Nicholson GC, Ward L, Bennett ST, Wuyts W, Van Hul W, Ralston SH 2002 Domain specific mutations in Sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum Mol Genet 11:2735-2739.
30. Falchetti A, Di Stefano M, Marini F, Del Monte F, Mavilia C, Strigoli D, De Feo ML, Isaia G, Masi L, Amedei A, Cioppi F, Ghinoi V, Maddali Bongi S, Di Fede G, Sfrerrazza C, Rini GB, Melchiorre D, Matucci-Cerenic M, Brandi ML 2004 Two novel mutations at exon 8 of Sequestosome 1 gene (SQSTM1) in an Italian series of patients affected by Paget's disease of bone (PDB). J Bone Miner Res 19:1013-1017.
31. Johnson-Pais TL, Wisdom JH, Weldon KS, Cody JD, Hansen MF, Singer FR, Leach RJ 2003 Three novel mutations in SQSTM1 identified in familial Paget's disease of bone. J Bone Miner Res 18:1748-1753.
32. Hocking LJ, Lucas GJA, Daroszewska A, Cundy T, Nicholson GC, Donath J, Walsh JP, Finlayson C, Cavey JR, Ciani B, Sheppard PW, Searle MS, Layfield R, Ralston SH 2004 Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: Genotype phenotype correlation, functional analysis and structural consequences. J Bone Miner Res 19:1122-1127.
33. Eekhoff EW, Karperien M, Houtsma D, Zwinderman AH, Dragoiescu C, Kneppers AL, Papapoulos SE 2004 Familial Paget's disease in The Netherlands: Occurrence, identification of new mutations in the sequestosome 1 gene, and their clinical associations. Arthritis Rheum 50:1650-1654.
34. Good DA, Busfield F, Fletcher BH, Lovelock PK, Duffy DL, Kesting JB, Andersen J, Shaw JT 2004 Identification of SQSTM1 mutations in familial Paget's disease in Australian pedigrees. Bone 35:277-282.
35. Vadlamudi RK, Joung I, Strominger JL, Shin J 1996 p62, a phosphotyrosine-independent ligand of the SH2 domain of p561ck, belongs to a new class of ubiquitin-binding proteins. J Biol Chem 271:20235-20237.
36. Lucas GJ, Hocking LJ, Daroszewska A, Cundy T, Nicholson GC, Walsh JP, Fraser WD, Meier C, Hooper MJ, Ralston SH 2005 Ubiquitin-associated domain mutations of SQSTM1 in Paget's disease of bone: Evidence for a founder effect in patients of British descent. J Bone Miner Res 20:227-231.
37. Daroszewska A, Hocking LJ, McGuigan FEA, Langdahl BL, Stone MD, Cundy T, Nicholson GC, Fraser WD, Ralston SH 2004 Susceptibility to Paget's disease of bone is influenced by a common polymorphic variant of Osteoprotegerin. J Bone Miner Res 19:1506-1511.
38. Wallace RG, Barr RJ, Osterberg PH, Mollan RA 1989 Familial expansile osteolysis. Clin Orthop 248:265-277.
39. Reddy SV, Singer FR, Mallette L, Roodman GD 1996 Detection of measles virus nucleocapsid transcripts in circulating blood cells from patients with Paget disease. J Bone Miner Res 11:1602-1607.
40. Hughes AE, Shearman AM, Weber JL, Barr RJ, Wallace RG, Osterberg PH, Kevin NC, Mollan RA 1994 Genetic linkage of familial expansile osteolysis to chromosome 18q. Hum Mol Genet 3:359-361.
41. Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, McCabe S, Elliott R, Scully S, Van G, Kaufman S, Juan SC, Sun Y, Tarpley J, Martin L, Christensen K, McCabe J, Kostenuik P, Hsu H, Fletcher F, Dunstan CR, Lacey DL, Boyle WJ 2000 RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 97:1566-1571.
42. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira DSA, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.
43. Hughes AE, Ralston SH, Marken J, Bell C, MacPherson H, Wallace RG, Van Hul W, Whyte MP, Nakatsuka K, Hovy L, Anderson DM 2000 Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet 24:45-48.
44. Johnson-Pais TL, Singer FR, Bone HG, McMurray CT, Hansen MF, Leach RJ 2003 Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis. J Bone Miner Res 18:376-380.
45. Palenzuela L, Vives-Bauza C, Fernandez-Cadenas I, Meseguer A, Font N, Sarret E, Schwartz S, Andreu AL 2002 Familial expansile osteolysis in a large Spanish kindred resulting from an insertion mutation in the TNFRSF11A gene. J Med Genet 39:E67.
46. Whyte MP, Hughes AE 2002 Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis. J Bone Miner Res 17:26-29.
47. Sparks AB, Peterson SN, Bell C, Loftus BJ, Hocking L, Cahill DP, Frassica FJ, Streeten EA, Levine MA, Fraser CM, Adams MD, Broder S, Venter JC, Kinzler KW, Vogelstein B, Ralston SH 2001 Mutation screening of the TNFRSF11A gene encoding receptor activator of NF kappa B (RANK) in familial and sporadic Paget's disease of bone and osteosarcoma. Calcif Tissue Int 68:151-155.
48. Wuyts W, Van Wesenbeeck L, Morales-Piga A, Ralston S, Hocking L, Vanhoenacker F, Westhovens R, Verbruggen L, Anderson D, Hughes A, Van Hul W 2001 Evaluation of the role of RANK and OPG genes in Paget's disease of bone. Bone 28:104-107.
49. Nance MA, Nuttall FQ, Econs MJ, Lyles KW, Viles KD, Vance JM, Pericak-Vance MA, Speer MC 2000 Heterogeneity in Paget disease of the bone. Am J Med Genet 92:303-307.
50. Good D, Busfield F, Duffy D, Lovelock PK, Resting JB, Cameron DP, Shaw JT 2001 Familial Paget's disease of bone: Non-linkage to the PDB1 and PDB2 loci on chromosomes 6p and 18q in a large pedigree. J Bone Miner Res 16:33-38.
51. Golob DS, McAlister WH, Mills BG, Fedde KN, Reinus WR, Teitelbaum SL, Beeki S, Whyte MP 1996 Juvenile Paget disease: Life-long features of a mildly affected young woman. J Bone Miner Res 11:132-142.
52. Janssens K, de Vernejoul MC, De FF, Vanhoenacker F, Van HW 2005 An intermediate form of juvenile Paget's disease caused by a truncating TNFRSF11B mutation. Bone 36:542-548.
53. Cundy T, Hegde M, Naot D, Chong B, King A, Wallace R, Mulley J, Love DR, Seidel J, Fawkner M, Banovic T, Callon KE, Grey AB, Reid IR, Middleton-Hardie CA, Cornish J 2002 A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. Hum Mol Genet 11:2119-2127.
54. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L. Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ 1997 Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
55. Chong B, Hegde M, Fawkner M, Simonet S, Cassinelli H, Coker M, Kanis J, Seidel J, Tau C, Tuysuz B, Yuksel B, Love D, Cundy T 2003 Idiopathic hyperphosphatasia and TNFRSF11B mutations: Relationships between phenotype and genotype. J Bone Miner Res 18:2095-2104.
56. Kimonis VE, Kovach MJ, Waggoner B, Leal S, Salam A, Rimer L, Davis K, Khardori R, Gelber D 2000 Clinical and molecular studies in a unique family with autosomal dominant limb-girdle muscular dystrophy and Paget disease of bone. Genet Med 2:232-241.
57. Caughey JE, Wynne JF, Jefferson N 1957 Dystrophia myotonica associated with familial Paget's disease (osteitis deformans) with sarcomata. J Bone Joint Surg Br 39-B:316-325.
58. McBride TI 1966 Paget's disease and muscular dystrophy. Report of an unusual association in one family. Scott Med J 11:238-243.
59. Tucker WS Jr, Hubbard WH, Stryker TD, Morgan SW, Evans OB, Freemon FR, Theil GB 1982 A new familial disorder of combined lower motor neuron degeneration and skeletal disorganization. Trans Assoc Am Physicians 95:126-134.
60. Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE 2004 Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36:377-381.
61. Wang Q, Song C, Li CC 2004 Molecular perspectives on p97-VCP: Progress in understanding its structure and diverse biological functions. J Struct Biol 146:44-57.
62. Lucas GJ, Mehta SG, Hocking LJ, Stewart TL, Cundy T, Nicholson GC, Walsh JP, Fraser WD, Watts GD, Ralston SH, Kimonis VE 2006 Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone. Bone 38:280-285.
63. Duran A, Serrano M, Leitges M, Flores JM, Picard S, Brown JP, Moscat J, Diaz-Meco MT 2004 The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev Cell 6:303-309.
64. Lowe J, Mayer J, Landon M, Layfield R 2001 Ubiquitin and the molecular pathology of neurodegenerative diseases. Adv Exp Med Biol 487:169-186.
65. Mizuno Y, Hori S, Kakizuka A, Okamoto K 2003 Vacuole-creating protein in neurodegenerative diseases in humans. Neurosci Lett 343:77-80.
66. Kuusisto E, Salminen A, Alafuzoff I 2002 Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: Possible role in tangle formation. Neuropathol Appl Neurobiol 28:228-237.
67. Zatloukal K, Stumptner C, Fuchsbichler A, Heid H, Schnoelzer M, Kenner L, Kleinert R, Prinz M, Aguzzi A, Denk H 2002 p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 160:255-263.